BioLine RX Ltd - ADR (BLRX) Up 1.69% in Premarket Trading

BioLine RX Ltd - ADR (BLRX) has risen Monday morning, with the stock increasing 1.69% in pre-market trading to 1.2. BLRX's short-term technical score of 30 indicates that the stock has traded less bullishly over the last month than 70% of stocks on the market. In the Biotechnology industry, which ranks 86 out of 146 industries, the stock ranks higher than 40% of stocks. BioLine RX Ltd - ADR has risen 8.26% over the past month, closing at $1.14 on February 12. During this period of time, the stock fell as low as $1.10 and as high as $1.44. BLRX has an average analyst recommendation of Strong Buy. The company has an average price target of $14.30.

BLRX has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on BLRX!

See Full BLRX Report

BioLine RX Ltd - ADR has a Long-Term Technical rank of 22. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 78% of the market scoring higher. In the Biotechnology industry which is number 51 by this metric, BLRX ranks better than 51% of stocks.

Important Dates for Investors in BLRX:

-BioLine RX Ltd - ADR is set to release earnings on 2024-03-27. Over the last 12 months, the company has reported EPS of $-0.75. -We do not have a set dividend date for BioLine RX Ltd - ADR at this time. Click Here To Get The Full Report on BioLine RX Ltd - ADR (BLRX)